Login / Signup

Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials.

Stefan D AnkerPiotr PonikowskiChristoph WannerEgon PfarrSibylle J HauskeBarbara PeilAfshin SalsaliIvana RitterAudrey Koitka-WeberMartina BrueckmannJoAnn LindenfeldWilliam T Abrahamnull null
Published in: Circulation (2021)
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • adipose tissue
  • skeletal muscle